ARCHIVES

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Plaza Dedicated At NIH In Honor Of Paul Rogers.

June 15, 2001